Left Menu
Development News Edition

Cipla shares gain over 5 pc; m-cap rises by Rs 3,021 cr

Shares of drug firm Cipla on Friday gained over 5 per cent after the company said it has received the final approval from the US health regulator for Dimethyl Fumarate capsules.

PTI | New Delhi | Updated: 25-09-2020 18:57 IST | Created: 25-09-2020 18:57 IST
Cipla shares gain over 5 pc; m-cap rises by Rs 3,021 cr

Shares of drug firm Cipla on Friday gained over 5 per cent after the company said it has received the final approval from the US health regulator for Dimethyl Fumarate capsules. The stock jumped 5.10 per cent to close at Rs 770.20 on the BSE. During the day, it rose by 5.97 per cent to Rs 776.60.

On the NSE, it gained 4.99 per cent to settle at Rs 770.10. The company's market valuation also rose by Rs 3,021.11 crore to Rs 62,104.11 crore. The newly approved product is a generic therapeutic equivalent version of Biogen IDEC Inc's Tecfidera.

Cipla has received final approval for its abbreviated new drug application (ANDA) for Dimethyl Fumarate DR (delayed release) capsules in the strengths of 120mg, 240mg and 120mg and 240mg from the United States Food and Drug Administration (USFDA), the company said in a regulatory filing. The capsule is indicated for the treatment of relapsing forms of multiple sclerosis..


TRENDING

OPINION / BLOG / INTERVIEW

Uganda COVID-19 response: Was off to a good start but reopening dwindled prospects

Uganda has shown success in using health information to enhance efficiency of disease surveillance, reporting and monitoring. The success, however, has critical challenges confronting it as the country resumes normal activities....

New farm bills in India: Focusing on farms or farmers?

... ...

Kenya’s COVID-19 response: Chaos amid lack of information

Confusing numbers and scanty information on how effective curfews and lockdowns have been in breaking transmission have amplified coordination and planning challenges in Kenyas response to COVID-19. Without accurate data, it is impossible t...

Farkhad Akhmedov: Calculating the price of impunity from the law

In insistences such as the battle over the Luna, Akhmedov has resorted to extreme legal machinations to subvert the High Courts decision and keep his assets from being seized. ...

Videos

Latest News

Deutsche Bank sees profit of $363 million as costs fall

Deutsche Bank reported a third-quarter profit of 309 million euros USD 363 million, its third straight quarterly profit this year, as it saw fewer losses from selling off unwanted assets and revenues rose at its investment bank. CEO Christi...

Czech Republic reports 15,663 new coronavirus cases, highest daily tally

The Czech Republic reported 15,663 new coronavirus cases for Oct. 27, its highest daily tally, health ministry data showed on Wednesday.The total numer of cases rose to 284,033 while deaths climbed to 2,547. The country has been struggling ...

SBI General Insurance H1 PAT grows 53 pc to Rs 300 cr

Private non-life insurer SBI General Insurance reported a 53 per cent growth in profit after tax at Rs 300 crore for the first half of the current financial year. It had reported a profit after tax of Rs 196 crore in the same period of the ...

Uzbekistan to speed up selling of state-owned business to private sector

Tashkent Uzbekistan, October 28 ANIXinhua Uzbek President Shavkat Mirziyoyev has approved a list of state-owned properties and enterprises to be sold to the private sector to speed up the privatization process, a presidential decree said We...

Give Feedback